USA – Intrinsic Capital Partners, a Conshohocken, Pa.-based private equity firm, closed a $102m growth equity fund.
Intrinsic Health Partners, L.P., invests in life science and technology businesses focusing on ancillary life science and technology companies that support the broader cannabis and hemp industries. Founded by principals Gerald Stahlecker, Cornelius Merlini and Goodwin, Intrinsic focuses on ancillary cannabis and hemp businesses. Key to the firm’s strategy is its deep network of operating advisors who bring decades of experience in healthcare, technology, consumer marketing and regulatory affairs. The advisors have engaged in supporting investment and segment diligence, regulatory evaluations and market risk assessments. They are also actively engaged in building and scaling Intrinsic’s portfolio companies, either as board directors or members of management.Intrinsic’s operator-centric investment model leverages a network of veterans of the consumer, life sciences and technology industries. This advisory group includes:To date, Intrinsic has committed $65m to four portfolio company investments, including ACT Laboratories, Inc. (lab testing), Treez, Inc. (business management software), Hound Labs, Inc. (marijuana and alcohol breathalyzer technology) and Elemental Brands, Inc. (hemp-derived consumer healthcare products). 11/11/2020
